CIChamplain Investment Partners, LLC
Institutional investor · Portfolio as of Q1 2019
Top Holdings120 positions
Integra Lifesciences Holdings | 5.5M | $305M | 2.7% | $55.72 | 0.00% | 1 qtr | First report 0 |
EVERPURE INC | 9.9M | $214.7M | 1.9% | $21.79 | 0.00% | 1 qtr | First report 0 |
WATERS CORP | 838,625 | $211.1M | 1.8% | $251.71 | 0.00% | 1 qtr | First report 0 |
TREEHOUSE FOODS INC | 3.2M | $207.6M | 1.8% | $64.55 | 0.00% | 1 qtr | First report 0 |
PALO ALTO NETWORKS INC | 816,340 | $198.3M | 1.7% | $40.48 | 0.00% | 1 qtr | First report 0 |
Blackbaud Inc | 2.5M | $196.7M | 1.7% | $79.26 | 0.00% | 1 qtr | First report 0 |
SPLUNK INC | 1.6M | $195.1M | 1.7% | — | — | 1 qtr | First report 0 |
EVEREST GROUP LTD | 889,250 | $192M | 1.7% | $187.46 | 0.00% | 1 qtr | First report 0 |
| 5.6M | $191.9M | 1.7% | $30.08 | 0.00% | 1 qtr | First report 0 | |
GALLAGHER ARTHUR J & CO | 2.3M | $177.6M | 1.5% | $71.78 | 0.00% | 1 qtr | First report 0 |
NORDSON CORP | 1.3M | $176M | 1.5% | $122.15 | 0.00% | 1 qtr | First report 0 |
APTARGROUP INC | 1.6M | $175.5M | 1.5% | $97.44 | 0.00% | 1 qtr | First report 0 |
MEDIDATA SOLUTIONS INC | 2.4M | $175.1M | 1.5% | — | — | 1 qtr | First report 0 |
ULTA BEAUTY INC | 498,510 | $173.8M | 1.5% | $348.73 | 0.00% | 1 qtr | First report 0 |
WILEY JOHN & SONS INC | 3.9M | $173.2M | 1.5% | $35.07 | 0.00% | 1 qtr | First report 0 |
FORTIVE CORP | 2M | $170.7M | 1.5% | $51.27 | 0.00% | 1 qtr | First report 0 |
New Relic Inc | 1.7M | $170M | 1.5% | — | — | 1 qtr | First report 0 |
TRACTOR SUPPLY CO | 1.6M | $158.9M | 1.4% | $17.27 | 0.00% | 1 qtr | First report 0 |
CATALENT INC | 3.9M | $158.8M | 1.4% | — | — | 1 qtr | First report 0 |
VERISK ANALYTICS INC | 1.2M | $156M | 1.4% | $127.36 | 0.00% | 1 qtr | First report 0 |
Champlain Investment Partners, LLC manages $11.5B across 120 positions as of Q1 2019. Top holdings: IART (2.7%), PSTG (1.9%), WAT (1.8%). Fund DNA: Steady Compounder. HoldingsIntel Score: 2/5.0.
First quarter we have for this fund: 120 positions, nothing earlier to compare. No standout high-conviction moves this quarter. Portfolio: $11.5B across 120 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer
Verify source filings on SEC EDGAR